Organization
Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University
16 abstracts
Abstract
Mechanism study on fig exosome-like nanoparticles inhibiting the progression of bone metastasis in breast cancer.Org: Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Key Laboratory of Minimally Invasive Surgery and Precision Treatment for Breast Cancer of Chongqing Municipal Health Commission, Department of Pathology, Southwest Hospital, Army Medical University, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University, Pancreatic Injury and Repair Key Laboratory of Sichuan Province, The General Hospital of Western Theater Command,
Abstract
Effect of transcription factor WT1 on triple-negative breast cancer metastasis through PFKFB4-mediated glycolysis.Org: Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University; Key Laboratory of Minimally Invasive Surgery and Precision Treatment for Breast Cancer of Chongqing Municipal Health Commission, Chongqing, China, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China, Department of Breast and Thyroid Surgery, Sounthwest Hospital, Army Medical University, Chongqing, China, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University; Department of Thoracic Surgery, the Eighth Medical Center of Chinese PLA General Hospital, Chongqing, China, Central Medical Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. L., Nanjing, China, Key Laboratory of Minimally Invasive Surgery and Precision Treatment for Breast Cancer of Chongqing Municipal Health Commission, Chongqing, China, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University,
Abstract
The impact of PD-L1 expression and co-mutations on outcome of KRAS-driven non-small-cell lung cancer.Org: Department of Thoracic Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan, Thoraxklinik, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), University Hospital Heidelberg,
Abstract
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.Org: Aix-Marseille University CHU Timone, APHM, Service d'Oncologie Multidisciplinaire & Innovations Thérapeutiques, CNRS UMR 5309-INSERM U1209, INP, Inst Neurophysiopathol,
Abstract
Impact of HER2 assay sensitivity on the ability to detect tumors with low to ultra-low HER2 expression: A TMA study on more than 10,000 tumors from more than 100 tumor entities.Org: University Medical Center Hamburg-Eppendorf, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University, Academic Hospital Fuerth,
Abstract
Ramucirumab, avelumab and paclitaxel (RAP) as second line treatment in esophagogastric adenocarcinoma: Final results of the phase 2 RAP trial (AIO-STO-0218).Org: Charité University Medicine Berlin, Department of Haematology, Lille University Hospital, Oncology and Cancer Immunology (CCM), Campus Virchow-Klinikum, Hematology Oncology Practice Eppendorf and University Cancer Center Hamburg (UCCH),
Abstract
Onco-PDO test utilizing patient-derived organoids (PDOs) and next-generation precision oncology in breast cancer.Org: Invitrocue Europe AG, Invitrocue Hong Kong Ltd, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University, Technical University of Munich (TUM), Department of Gynecology, Puyang Oilfield General Hospital, Puyang, China,
Abstract
Human epidermal growth factor receptor 2/3 (HER2/HER3) expression in higher-grade meningioma.Org: Medical University of Vienna, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University, Ruprecht-Karls University Heidelberg, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center,
Abstract
Association of ultra-sensitive ctDNA assay to identify actionable variants and response to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma.Org: Skin Cancer Center, University Hospital Leipzig, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany, Personalis, Inc.,
Abstract
Quantitative analysis of MMR deficiency in dMMR/MSI high CRC and levels of instability: Implications for ICI therapy of dMMR tumors.Org: Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University, Clinical Hospital “Acibadem Sistina”, University Clinic for Radiotherapy and Oncology, University Clinic for Abdominal Surgury, Center for Genetic Engineering and Biotechnology "Georgi D. Efremov",
Abstract
Class II and class III BRAF mutations in patients with advanced non-small cell lung cancer (NSCLC): Clinical characteristics, mutation patterns, and survival outcomes.Org: Network Genomic Medicine, University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne,
Abstract
AI-based pathologic biomarker for pathologic downstaging in patients with muscle-invasive bladder cancer undergoing cystectomy after neoadjuvant nivolumab, gemcitabine, and cisplatin: BLAAST-1 Trial.Org: Valar Labs, Inc., Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Huntsman Cancer Institute, Hunstman Cancer Institute at the University of Utah,
Abstract
Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors.Org: University Medical Center Hamburg-Eppendorf, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University, Academic Hospital Fuerth,
Abstract
Fully automated prostate cancer identification using multiplex fluorescence immunohistochemistry to assess prognosis markers on a single tissue section.Org: Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University, University Medical Center Hamburg-Eppendorf, University Medical Center Hamburg-Eppendorf (UKE), Martini-Klinik am UKE, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy,
Abstract
Comprehensive analysis of the mutational status of early colon cancer: Real world data from the AIO ColoPredict registry study.Org: Institut für Pathologie, Georgius Agricola Stiftung Ruhr, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, Winship Cancer Institute of Emory University, Atlanta, GA, Emory University, Atlanta, GA, Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, Department of Medicine, Massachusetts General Hospital, Boston, MA, Department of Medicine, Emory University School of Medicine, Atlanta, GA, Department of Urology, Emory University School of Medicine, Atlanta, GA, Oncology and Palliative Care Units, Ruhr-University Bochum,
Abstract
BALANCE BETWEEN HEPATOCYTE GROWTH FACTOR (HGF) AND TRANSFORMING GROWTH FACTOR (TGF-BETA1) IN RENAL BIOPSIES OF PATIENTS WITH LUPUS NEPHRITISOrg: Departement of Rheumatology, Department of Nephrology and Hypertension, St. Marianna University School of Medicine, Kawasaki, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University, Catholic University of Rome, Rome, University of Udine,